11 May 2018 - The plan announced by President Trump and Alex M. Azar II, the secretary of health and human services, on Friday would give private entities more tools to negotiate better deals on behalf of consumers, insurers and employers.

President Trump vowed on Friday to “bring soaring drug prices back down to earth” by promoting competition among pharmaceutical companies, and he suggested that the government could require drugmakers to disclose prices in their ubiquitous television advertising.

But he dropped the popular and populist proposals of his presidential campaign, opting not to have the federal government directly negotiate lower drug prices for Medicare. And he chose not to allow American consumers to import low-cost medicines from abroad.

Read New York Times article